Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

GMS Q4 EPS $2.09 Beats $1.88 Estimate, Sales $1.29B Beat $1.26B Estimate

GMS (NYSE:GMS) reported quarterly earnings of $2.09 per share which beat the analyst consensus estimate of $1.88 by 11.17 percent. This is a 95.33 percent increase over earnings of $1.07 per share from the same period
byBenzinga Newsdesk
June 23, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

GMS (NYSE:GMS) reported quarterly earnings of $2.09 per share which beat the analyst consensus estimate of $1.88 by 11.17 percent. This is a 95.33 percent increase over earnings of $1.07 per share from the same period last year. The company reported quarterly sales of $1.29 billion which beat the analyst consensus estimate of $1.26 billion by 2.30 percent. This is a 38.27 percent increase over sales of $932.20 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cyclo Therapeutics On Track To Commence Enrollment & Dosing Of Phase 2 Study Of Trappsol Cyclo For Treatment Of Alzheimer’s Disease Before Year End

By Benzinga Newsdesk
Today, 3:58 PM
  – Company on track to commence enrollment and dosing of Phase 2 study of Trappsol® Cyclo™ for the treatment of Alzheimer's disease before year end – Ongoing advancement of global pivotal study (TransportNPC™) evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 (NPC1)

CYTH